文献速递腹部MR

多频MRE预测胰腺癌侵袭性与患者生存

Multifrequency magnetic resonance elastography for predicting pancreatic cancer aggressiveness and patient survival.
PubMed 文献 · Eur Radiol · 2026-08-14

本研究纳入96例未经治疗的胰腺癌患者,行多频磁共振弹性成像,测量肿瘤中心、周边及整体的硬度与流度。结果显示周边流度与肿瘤分期、神经侵犯、淋巴结转移及远处转移正相关,在48例R0切除患者中周边流度较高者无病生存期更短,且为独立预测因子。

要点

  • 胰腺癌周边流度高于中心流度,提示肿瘤周边生物力学特性更具侵袭意义
  • 周边流度高与分期晚、神经侵犯、淋巴结及远处转移相关,阅片时应关注周边区流度参数
  • R0切除患者中周边流度高预示更短无病生存期,可辅助风险分层与新辅助治疗决策

核心结论

  • 多频MRE量化的肿瘤生物力学特性可预测胰腺癌侵袭性与患者生存
  • 周边肿瘤流度与胰腺癌侵袭性相关,并独立预测R0切除患者无病生存期

研究设计与样本

  • 回顾性研究,纳入96例未经治疗的胰腺癌患者,2018年9月至2024年5月期间接受多频MRE
  • 生成高分辨率参数图,测量中心、周边及全肿瘤区域的硬度与流度
  • 分析MRE参数与肿瘤分期、分级、血管及神经侵犯、区域淋巴结肿大、远处转移的相关性
  • 用Kaplan-Meier和Cox比例风险模型分别在R0切除与非R0切除患者中识别预后因素

关键影像表现/征象

  • 周边流度高于中心流度(1.23±0.25 vs 0.95±0.19 rad,p<0.001),硬度无区域差异(p=0.07)

诊断标准与关键数值

  • 肿瘤硬度与血管侵犯正相关(ρ=0.21,p=0.04)
  • 周边流度与肿瘤分期正相关(ρ=0.28,p=0.007)
  • 周边流度与神经侵犯正相关(ρ=0.31,p=0.02)
  • 周边流度与区域淋巴结肿大正相关(ρ=0.29,p=0.005)
  • 周边流度与远处转移正相关(ρ=0.26,p=0.01)

临床应用与阅片要点

  • 测量胰腺癌周边区域流度比中心更能反映肿瘤侵袭性,报告中宜单独关注周边参数图
  • 周边流度升高提示血管、神经侵犯及转移风险增加,可用于术前风险分层
  • 对拟行R0切除患者,周边流度高者无病生存期可能更短,可考虑加强辅助治疗或筛选新辅助治疗对象

局限性

  • 回顾性研究设计存在选择偏倚可能

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the spatial heterogeneity of viscoelastic properties in pancreatic cancer, to correlate MR elastography (MRE) parameters with clinicopathological factors indicating tumor aggressiveness, and to identify risk factors for patient survival.

MATERIALS AND METHODS: This retrospective study included 96 treatment-naive pancreatic cancer patients undergoing multifrequency MRE between September 2018 and May 2024. High-resolution parametric maps were generated to measure stiffness and fluidity in central, peripheral, and whole-tumor regions. Correlations between MRE parameters and tumor stage, grade, vascular and perineural invasion, regional lymphadenopathy, and distant metastasis were analyzed. Kaplan-Meier and Cox proportional hazards models were used to identify prognostic factors in patients with and without R0 resection, respectively.

RESULTS: Peripheral fluidity of the tumor was higher than central fluidity (1.23 ± 0.25 vs 0.95 ± 0.19 rad, p < 0.001), whereas stiffness showed no zonal difference (p = 0.07). Tumor stiffness correlated positively with vascular invasion (ρ = 0.21, p = 0.04). Peripheral tumor fluidity correlated positively with tumor stage (ρ = 0.28, p = 0.007), perineural invasion (ρ = 0.31, p = 0.02), regional lymphadenopathy (ρ = 0.29, p = 0.005), and distant metastasis (ρ = 0.26, p = 0.01). In 48 R0-resected patients, higher peripheral fluidity was associated with shorter disease-free survival (DFS) (9.1 vs 19.4 months, p = 0.009) and was identified as an independent predictor of shorter DFS (hazard ratio, 2.15; 95% confidence interval: 1.03, 4.50; p = 0.04).

CONCLUSION: Tumor biomechanical properties quantified by in vivo multifrequency MRE predict pancreatic cancer aggressiveness and patient survival.

KEY POINTS: Question Pretreatment identification of aggressive pancreatic cancer remains challenging. Non-invasive imaging biomarkers are needed to stratify patient risk and optimize individualized treatment strategies. Findings Peripheral tumor fluidity quantified by multifrequency MRE correlates with pancreatic cancer aggressiveness and independently predicts DFS in patients with R0-resected pancreatic cancer. Clinical relevance MRE-derived peripheral fluidity provides a biophysical marker for pancreatic cancer aggressiveness. This facilitates risk stratification and identifying high-risk candidates for targeted neoadjuvant therapy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wang, Liu, Dai, et al. Multifrequency magnetic resonance elastography for predicting pancreatic cancer aggressiveness and patient survival. Eur Radiol. 2026. PMID: 42601528. doi:10.1007/s00330-026-12824-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。